Company Filing History:
Years Active: 2009-2012
Title: Kevin P. Landolfo: Innovator in Angiogenesis
Introduction
Kevin P. Landolfo is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of medicine, particularly in the area of angiogenesis. With a total of 2 patents, his work focuses on innovative methods to improve heart health.
Latest Patents
Kevin's latest patents include a method for inducing angiogenesis in the heart of a patient. This invention encompasses a unit dose pharmaceutical composition that contains an angiogenic agent, typically ranging from about 5 ng to less than 135,000 ng. The preferred agent is basic FGF (FGF-2). The patent outlines methods for administering this agent directly into the myocardium to enhance myocardial perfusion and vascular density. Additionally, it describes treatment methods for coronary artery disease and myocardial infarction through similar administration techniques.
Career Highlights
Throughout his career, Kevin has worked with prominent organizations such as Novartis Vaccines & Diagnostics and Duke University. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his innovative contributions.
Collaborations
Some of Kevin's notable coworkers include David T. Hung and Brian H. Annex. Their collaborative efforts have likely played a role in advancing the research and development of his patented methods.
Conclusion
Kevin P. Landolfo's work in angiogenesis represents a significant advancement in medical science. His innovative patents and collaborations highlight his commitment to improving patient outcomes in heart health.